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ABSTRACT 
 
Probiotics are over-the-counter products marketed for enhancing human health. Online 
information has been key in promoting probiotics worldwide. However, only few rigorous 
clinical studies have met the stringent criteria required to establish the efficacy and safety of 
probiotics. The present study was undertaken to assess the information quality of webpages 
referring to probiotics and to compare the recommendations available online with the 
information collected from trusted scientific sources. 
We evaluated 150 webpages returned by Google searching “probiotics” in terms of typology 
of website, health information quality based on the JAMA score and the HONcode 
certification, as well as completeness of the information based on the presence of 4 criteria: (1) 
links to scientific references supporting health claims, (2) cautionary notes about level of 
evidence for alleged benefits, (3) safety considerations and (4) regulatory status. We then 
enumerated the health claims mentioned online and the corresponding clinical trials and 
reviews registered in the Cochrane library. Finally, the conclusions of Cochrane reviews were 
used to assess the level of scientific evidence of the information available through Google 
search. 
HON-certified websites were significantly more frequent in the top ten websites than in the 
remaining websites. In terms of completeness of information, only 10% of webpages met all 
four criteria,, 40% had a cautionary note on benefits, 35% referred to scientific literature and 
only 25% mentioned potential side effects.  
The results of the content  analysis led us to conclude that: (1) the most frequent typologies of 
webpages returned by Google are commercial and news, (2) commercial websites on average 
provide the least reliable information and (3) significant numbers of claimed benefits of 
probiotics are not supported by scientific evidence. This study highlights important biases in 
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the probiotics information available online, underlining the need to to improve the quality and 
objectivity of information provided to the public. 
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INTRODUCTION 
 
The World Health Organization defines probiotics as “live microorganisms which, when 
administered in adequate amounts, confer a health benefit to the host”1. Although the 
association between probiotics and health has already been formulated at the beginning of the 
20th century by Elie Metchnikoff, Nobel Prize Winner in Physiology2, the development of 
probiotics as health products is quite recent, in relation with the growing interest in the 
microbiome3,4.  
The US probiotics market was estimated to be over 40 billion $ in 2017 whereas the European 
market is trailing behind, probably due to the stricter regulation for the nutrition and health 
claims on food supplements (Regulation (EC) No 1924/2006)5. Nevertheless, the probiotics 
market continuously expands with the globalization of online sales. Indeed, together with other 
over-the-counter medicinal products, probiotics are increasingly popular and widely advertised 
on the Internet6. It is therefore important to assess the trustworthiness of the probiotics 
information that can be found online. For this purpose, we took advantage of an established 
methodology previously used to analyse health information quality on antioxidants and 
vaccines7,8,9.  
Herein, data collected from 150 webpages returned by Google when searching for the term 
“probiotics” were analyzed for their accuracy and completeness. The Google search engine 
was used since it is the most used worldwide, with a 75% market share throughout 201710. We 
then compared the results of this analysis with the information available in the Cochrane 
library11, an established source of evidence-based medical information. 
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METHODS 
 
Data collection 
The search term “probiotics” was entered on July 23, 2018 in http://google.com using the 
browser Google chrome (Google LLC, Mountain View, CA, USA) after logging out from any 
Google account, clearing caches and browsing history to avoid the results to be influenced by 
previous searches and browsing behaviour [the so-called “bubble effect”]. The search was 
performed from Brussels, Belgium. The first 200 URL returned in the search engine result page 
(SERP) were transferred to a spreadsheet using the Google extension SEOquake (SEMrush, 
Trevose, PA, USA). Each URL was then visited and assessed until we reached a total of 150 
websites eligible for the study. Exclusion criteria were duplicates, irrelevant websites, websites 
with paywalls or requiring log-in, video lasting more than 15 minutes, or dead links. 
 
Classification of websites 
The ten URLs that appeared first upon Google search were qualified as "top ten". Assessment 
of each URL was performed according to the following parameters: 
1. Classification of the website according to typology as follows: commercial (C), 
governmental (G), news (N), health portal (HP), non-profit organization (NP), 
professional (P), scientific journals (SJ) and other (O) as previously described11 
(examples of this classification are provided in Supplementary Table 1). This 
classification was performed independently by two researchers (M.N. and P.G.). Inter-
rater variability was assessed using GraphPad. The observed agreements were 133 of 
150, reaching a very good strength of agreement [89% of the observations, resulting in 
a weighted kappa = 0.841, 95% confidence interval (0.772, 0.910)]. The final typology 
resulted from a consensus between the two researchers.  
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2. The Journal of the American Medical Association (JAMA) score. This highlights the 
presence of four elements: authors’ name, date of publication or update, indication of 
the website’s owner and references to sources12. Each criterion scores 1 unit, so that the 
JAMA score ranges from 0 to 4. The JAMA score classification was performed by one 
author (MN) and double checked by a second author (PG), and disagreements discussed 
and resolved. 
3. The presence or absence of the HONcode seal on the page. The HONcode certification 
is provided by an independent organization (Health-on-the-net, Lausanne, Switzerland) 
and addresses the reliability and the credibility of the information found on the website 
based on eight criteria: authoritativeness (qualifications of the authors), 
complementarity (supporting but not replacing doctor-patient relationship), privacy, 
attribution (citing the sources), justifiability (baking clsaims relating to benefits), 
transparency (contact information and identity of editor and webmaster), financial 
disclosure and a clear distinction of adversisements from editorial content13. Of note, 
the JAMA score and the HONcode are trustworthiness indicators that do not rate the 
content of the information provided by the website13. The presence of the HONcode 
seal was assessed by one author (MN) and cross-validated by a second author (PG). 
4. The diseases or biological processes (e.g. skin health, mental health, cardiovascular 
diseases (CVD), gastrointestinal health, cancer, uro-genital health, immune system 
support, respiratory health) mentioned in the context of potential benefits of probiotics. 
This list was compiled based on the indications mentioned in the webpages 
5. The species of the microorganisms present in the probiotics mentioned. 
6. The completeness of the scientific information found on each webpage. For this, we 
looked for mentions regarding (i) regulatory framework; (ii) relevant scientific 
documentation; (iii) caution about potential benefits and (iv) potential side effects of 
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probiotics. Each item was given a score of "1" ao that the completeness score ranged 
from 0 to 4. Examples for this classification are provided in Supplementary Table 2. 
A requirement for scoring webpages for any of the items above was that the information had 
to be available within three clicks. The rationale behind is that information quality is studied 
from the perspective of the lay public who will unlikely go beyond 3 clicks to search for 
information14.  
It should be noted that a webpage could mention more than one disease or biological process, 
and more than one microorganism. These were considered and reviewed separately. 
 
Comparison of online claims with evidence-based information in the Cochrane library 
We used the information in the Cochrane library10 as a proxy for the strength of the scientific 
evidence available on the health benefits of probiotics in specific indications. As mentioned in 
Cochrane website, Cochrane review attempt to identify, appraise and synthesize all the 
empirical evidence that meets pre-specified eligibility criteria to answer a specific research 
question15. We recorded the numbers of Cochrane reviews as well as the numbers of clinical 
trials present in the Cochrane library for each of the indications mentioned in the SERP. 
Conclusions on the evidence-based benefits of probiotics for the quoted indications were drawn 
from the abstracts of the reviews. The analysis was completed by the end of February 2019. 
 
Statistical analysis 
Data referring to categorical variables (scores) are expressed as median and interquartile 
range (IQR). To compare categorical variables (JAMA score, completeness score in different 
typologies of websites a non-parametric two-tailed Kruskal-Wallis multiple comparison test, 
followed by the Dunn’s post test was used.To compare the completeness score in two groups 
(e.g. vcommercial versus non-commercial websites), a Mann-Whitney test was used. 
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Comparison of the frequency of website typologies in the top ten webpages returned by 
Google versus the remaining 140 webpages was dove usinga two-tailed Fisher’s exact 
test.This was also used when comparing the frequency of HONcode-certified webpages in tne 
top ten results versus the remaining 140 websites.The statistical analysis was pre-defined and 
followed exactly the same design used in our previous studies7,8,9. 
 
RESULTS 
 
Distribution of websites by typology 
Of the 150 websites analyzed, the most frequent typology was “commercial” websites (43%) 
followed by “news” (31%); all other typologies present accounted for less than 10% (Figure 
1). We also analyzed the top 10 websites returned separately as they have a higher visibility 
and most Internet users don’t go past the first page of results returned. A different pattern was 
observed for the top ten webpages returned by Google, where the most frequent typology was 
“health portal” (44%), followed by “commercial” (22%). This over-representation of “health 
portals” was statistically significant (P < 0.0005 by a Fisher’s test).  
 
Analysis of trustworthiness criteria: JAMA score 
The overall trustworthiness of each webpage was assessed by calculating the JAMA score as 
defined in the Methods section. The median JAMA score was 3, IQR [2.5,4], and was not 
significantly different in the top ten websites.  
Figure 2 displays the median JAMA score of websites according to the different typologies. 
Commercial websites had the lowest JAMA score of all typologies, with a significantly lower 
median than professional, health portal and news websites. 
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Analysis of trustworthiness criteria: HONcode certification 
In total, only 13 websites displayed the HONcode certification. The frequency of websites 
certified by HONcode was significantly higher in the top ten websites (4/9, 44%) than in the 
remaining websites (9/141, 6%; P < 0.005 by a two-tailed Fisher’s test).  
 
Completeness of information  
Completeness of the scientific information available on websites was evaluated based on the 
following 4 criteria: (1) links to scientific references supporting health claims, (2) cautionary 
notes about level of evidence for alleged benefits, (3) safety considerations and (4) regulatory 
status. As shown in Figure 3, most websites provide poor information, with over 60% scoring 
zero and less than 10% scoring positively for the 4 criteria. When the 4 criteria were analyzed 
separately, 40% of webpages had a cautionary note about probiotics health benefits suggesting 
that additional research need to be done, 35% were referencing to scientific literature when 
mentioning defined probiotics indications, 25% mentioned potential side effects, whereas only 
15% mentioned regulatory provisions. 
Of note, the completeness score was significantly higher in the top ten websites (median 2, 
IQR [1, 3.5]) than in the remaining websites (median 1, IQR [0, 2]) (P < 0.005 using Mann-
Whitney’s test).  
Figure 4 depicts level of completeness by website typology. Multiple comparison showed that 
commercial websites had the lowest completeness score. The median score for commercial 
websites was significantly lower than that of non-commercial websites (median 0, IQR [0,3] 
versus median 2, IQR [0,4]; P < 0.0001 by Mann-Whitney’s test). The highest completeness 
score was observed in governmental websites and scientific journals’ websites.  
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The information about the exact content of the probiotic products was highly variable. Of note, 
29 out of the 150 webpages (19%) did not provide any information on the bacterial strains 
composing probiotics.  
 
Comparing information online and evidence-based information from the Cochrane 
organization 
To get further insight in the accuracy and completeness of the information contained in the 150 
analyzed webpages, we first extracted and ranked the clinical settings for which probiotics 
were claimed to be beneficial (Figure 5, A). This was done referring to the nine therapeutic 
areas described in the methods. Of the 150 websites, 9 did not make any claim about their 
usefulness in a disease while only one mentioned all nine types for indication analyzed. The 
median number of claims mentioned was 3, IQR [1.75, 4]. We then enumerated the number of 
clinical trials registered in the Cochrane Central Register of Controlled Trials (Figure 5, B), as 
well as the number of reviews performed by Cochrane Review Groups (Figure 5, C). Gastro-
intestinal disorders are the most often referred online claims (132 websites, 88%) and also the 
subject of the highest number of clinical trials and Cochrane reviews. In contrast, immune 
enhancement which is the second most referred online claim (93 websites, 62%) has been 
barely investigated in clinical trials and has not been reviewed at all by Cochrane Review 
Group. A similar situation is observed for mental disorders and risk factors for cardiovascular 
diseases, with claims which are not supported by any Cochrane review. 
For each claim (which refers to a therapeutic indication), we extracted the level of scientific 
evidence based on the terminology used by the Cochrane Review Group (Table 1). Among 
gastrointestinal disorders, Cochrane reviews support online claims regarding infectious 
diarrhea, including Clostridium difficile-associated colitis. However, there is still uncertainty 
about which probiotics should be used for which groups of people, and also to assess the cost 
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effectiveness of this treatment. Cochrane reviews also support the use of probiotics in the 
prevention of necrotizing enterocolitis in preterm infants, but with insufficient data regarding 
the benefits and the potential adverse effects in the most at risk infants. In contrast, no evidence 
was found in Cochrane reviews regarding the benefits of currently used probiotics in cancer, 
obesity and respiratory disorders. For the other indications, the level of evidence is low or 
moderate. 
Finally, for each of the four levels of evidence in Cochrane reviews we enumerated the number 
of webpages referring to probiotics health claims. As shown in fig 6, only 77 out of the 325 
online claims (23%) are supported by substantiated scientific evidence according to Cochrane 
reviews. On the other hand, 66 out of 325 online claims (20%) are not supported by any 
scientific evidence in the current state of knowledge. 
 
DISCUSSION 
Health literacy is increasingly important to ensure that citizens take the best advantage of 
marketed health products. In the current era where distrust in medical experts and health 
authorities is widespread, individual consumption of over-the-counter health products is 
largely guided by information collected on the Internet. Since probiotics escape scrutinization 
by regulatory authorities, it is of utmost importance to get insight into the level of 
trustworthiness provided by online information on their benefits and risks. 
First, we observed that a high proportion (43%) of the websites returned by Google search on 
probiotics are of commercial nature, although these had a lower ranking as there were only 
22% commercial websites in the top ten page returned by Google. Commercial websites scored 
the lowest both in terms of JAMA score and HONcode certification. Of note, despite only a 
small number (13) of websites had the HONcode certification, the frequency of certified 
website was significantly higher in the top 10 results, suggesting that the HONcode 
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certification may be considered authoritative in the information quality algorithm used by 
Google. Although “health portal” and “news" websites seem more trustworthy according to 
these criteria, the information they provide might still be biased by the interest of their private 
sponsors.  One might assume that governmental websites supported by public sources might 
be the most reliable source of information but unfortunately, they are few and none is returned 
among the top ten upon Google search.  
We then investigated the completeness score of the webpages by a methodology based on four 
main criteria, as in a previous study on a different topic16. Strikingly, over 60% of webpages 
scored 0 whereas less than 10% scored 4, with commercial websites again ranking in the lowest 
range (Fig. 3). The top ten websites showed a significantly higher completeness score 
indicating that this aspect of information quality is reflected in the Google algorithm used for 
the ordering of websites.  In terms of consumer protection, information on the potential risks 
associated with the use of probiotics is especially important. Unfortunately, only 25% of 
webpages (and only 8% of the commercial ones) include safety considerations and refer to 
possible side effects. Moreover, the assessment by regulatory authorities is mentioned in only 
15% of all webpages, and 2% of the commercial ones. As a matter of fact, claims on the benefits 
and risks of probiotics in human diseases have not been approved neither by the US Food and 
Drug Administration (FDA) nor the European Food Safety Authority (EFSA) that are 
responsible for probiotics regulation in US and Europe, respectively. Although the overall 
safety profile of probiotics seem favorable, there are isolated reports of fungemia and 
bacteremia related to probiotics administration in  immunocompromised individuals including 
neonates with very low birth weights 17 18. The latter cases are especially important to consider 
since prevention of necrotizing enterocolitis is one of the few clinical settings in which the 
efficacy of probiotics is best established according to Cochrane reviews. 
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We acknowledge that the current study has limitations which might influence the interpretation 
of our findings. Obviously, the websites returned by Google search depend on the date of the 
search and the search terms used. Furthermore, Cochrane reviews might fall short in defining 
the level of scientific evidence for clinical benefit. They are often based on meta-analyses of 
trials that are heterogeneous in terms of clinical indications, design, as well as composition and 
formulation of probiotics compounds. These shortcomings affect both studies published in the 
scientific literature and the online information. As a consequence, both health professionals 
and lay people are exposed to incomplete information regarding probiotics.  
We conclude that the high level of uncertainty for most health claims found online hinders the 
rational use of probiotics, leaving the field open to unsubstantiated allegations and misuse. 
With the growing interest in therapeutic interventions targeting the microbiome, there is a clear 
need for a new regulatory framework and new policies regarding communication on the 
benefits and risks of probiotics. 
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FIGURES LEGENDS 
Figure 1. Distribution of websites by typology. Data show the percentage of websites in the top ten 
results (n = 9, as one of the websites ranked in the top ten by Google was a duplicate) and the total 
number of websites in the search (n = 150). 
 
Figure 2. JAMA score by typology of website. Data are reported as median and interquantile range. 
Significantly different commercial websites (*P < 0.05, **P < 0.005, ****P < 0.0001; two-tailed 
Kruskal-Wallis multiple comparison test, followed by the Dunn’s post test). Number of websites: C, 
64; G, 5; N, 46; HP, 8; NP, 3; O, 13; P, 9; SJ, 2. 
 
Figure 3. Distribution of websites according to the completeness of scientific information score. 
Data illustrate the number of websites ranking from 0 to 4 in the completeness score.  
 
Figure 4. Completeness score by typology of website. (A) Data are reported as median and 
interquantile range. (**P < 0.005, ****P < 0.0001; significantly different from commercial websites by 
a two-tailed Kruskal-Wallis test, followed by the Dunn’s post test). (B) Breakdown of the four 
components per typology. 
 
Figure 5. Number of websites, trials and meta-analyses in the Cochrane database by indications. 
Data indicates the number of occurrences of an indication in websites (A), in clinical trials (B) and in 
reviews (C) 
 
Figure 6. Number of online claims with different levels of scientific evidence according to 
Cochrane reviews. Values do not add up to 150 as webpages can mention more than one probiotics’ 
benefit. 
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TABLES 
Table 1. Level of scientific evidence for online health claims for probiotics 
Clinical setting 
 
 
Evidence* 
 
 
 
N 
Google 
pages** 
 
 
 
 
GI disorders 
 
 
Infectious diarrhea 
(including Clostridium difficile colitis) 
✓ 
 24 
Necrotizing enterocolitis ✓ 18 
Irritable bowel syndrome ≈ 41 
Antibiotic-associated diarrhea ≈ 45 
Ulcerative colitis ∼ 16 
Pouchitis ∼ 6 
Crohn's disease ∼ 8 
Food intolerance ∼ 23 
 
Urogenital 
disorders 
Urinary ∼ 21 
Vaginal ∼ 35 
 
Skin disorders Eczema ∼ 22 
 
Weight disorders ✕ 24 
 
Respiratory disorders ✕ 23 
 
Cancer 
Colorectal ✕ 9 
Bladder ✕ 4 
Liver ✕ 2 
Lung ✕ 1 
Stomach ✕ 1 
Breast ✕ 1 
Cervical ✕ 1 
 
* Derived from conclusions of Cochrane reviews. green (✓) = established evidence; yellow (≈) = 
moderate evidence; orange (∼) = low evidence; red (✕) = no evidence. 
 16 
** Number of health claims per clinical setting within the 150 websites analyzed. 
  
 17 
REFERENCES 
1.  FAO, WHO. Guidelines for the Evaluation of Probiotics in Food. 2002:1-11. 
http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf. 
2.  Podolsky SH. Metchnikoff and the microbiome. Lancet. 2012;380(9856):1810-1811. 
doi:10.1016/S0140-6736(12)62018-2 
3.  Hoffmann DE, Fraser CM, Palumbo F, Ravel J, Rowthorn V, Schwartz J. Probiotics: 
achieving a better regulatory fit. Food Drug Law J. 2014;69(2):237-272, ii. 
http://www.ncbi.nlm.nih.gov/pubmed/25163211. Accessed April 14, 2019. 
4.  Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and 
health. BMJ. 2018;361:36-44. doi:10.1136/bmj.k2179 
5.  Parliament THEE, Council THE, The OF, Union P. 30.12.2006.; 2006. 
6.  Bessell TL, Anderson JN, Silagy CA, Sansom LN, Hiller JE. Surfing, self-medicating 
and safety: buying non-prescription and complementary medicines via the internet. 
BMJ Qual Saf. 2003;12(2):88-92. doi:10.1136/QHC.12.2.88 
7.  Aslam R, Gibbons D, Ghezzi P. Online information on antioxidants : information 
Quality indicators , commercial interests , and ranking by google. Front Public 
Heakth. 2017;5(April):1-9. doi:10.3389/fpubh.2017.00090 
8.  Arif N, Al-Jefri M, Bizzi IH, et al. Fake News or Weak Science? Visibility and 
Characterization of Antivaccine Webpages Returned by Google in Different 
Languages and Countries. Front Immunol. 2018;9:1215. 
doi:10.3389/fimmu.2018.01215 
9.  Cassa Macedo A, Oliveira Vilela de Faria A, Ghezzi P. Boosting the immune system, 
from science to myth: analysis the infosphere with Google. Frontiers in medicine. 
2019 Jul 25;6:165. 
9.  Mangles C. Search Engine Statistics. Smart Insights. 
 18 
https://www.smartinsights.com/search-engine-marketing/search-engine-statistics/. 
Published 2018. Accessed September 13, 2018. 
11.  Cochrane library. https://www.cochranelibrary.com/. Published 2010. 
12.  Silberg WM, Lundberg GD, Musacchio RA. Assessing, Controlling, and Assuring the 
Quality of Medical Information on the Internet. JAMA. 1997;277(15):1244. 
doi:10.1001/jama.1997.03540390074039 
13.  Boyer C. Health on the Net is the Quality Standard for Information You can Trust. 
Health on the Net Foundation. 
https://www.hon.ch/Global/pdf/TrustworthyOct2006.pdf. Published 2013. Accessed 
September 13, 2018. 
14.  Joshua P. Testing the Three-Click Rule. User Interface Engineering. 
https://articles.uie.com/three_click_rule/. Published 2003. Accessed April 4, 2019. 
15.  Cochrane Database of Systematic Reviews. 
https://www.cochranelibrary.com/cdsr/about-cdsr. Accessed April 13, 2019. 
16.  Manley L, Ghezzi P. The quality of online health information on breast augmentation. 
Br Assoc Plast Reconstr Aesthetic Surg. 2018;71(10):e62-e63. 
doi:10.1016/j.bjps.2018.07.023 
17.  Cohen PA. Probiotic Safety - No guarantees. JAMA Intern Medicien. 2018;178(12). 
doi:10.1001/jamainternmed.2018.5403 Conflict 
18.  Suez J, Zmora N, Segal E, Elinav E. The pros , cons , and many unknowns of 
probiotics. Nat Med. 2019;25(May). doi:10.1038/s41591-019-0439-x 
  
 19 
FIGURES + LEGENDS 
 
Figure 1. Distribution of websites by typology. Data show the percentage of websites in the top ten 
results (n = 9, as one of the websites ranked in the top ten by Google was a duplicate) and the total 
number of websites in the search (n = 150). 
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Figure 2. JAMA score by typology of website. Data are reported as median and interquantile range. 
Significantly different from commercial websites (*P < 0.05, **P < 0.005, ****P < 0.0001; two-tailed 
Kruskal-Wallis multiple comparison test, followed by the Dunn’s post test). Number of websites: C, 
64; G, 5; N, 46; HP, 8; NP, 3; O, 13; P, 9; SJ, 2. 
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Figure 3. Distribution of websites according to the completeness of scientific information score. 
Data illustrate the number of websites ranking from 0 to 4 in the completeness score.  
 
 
Figure 4. Completeness score by typology of website. (A) Data are reported as median and 
interquantile range. (**P < 0.005, ****P < 0.0001; significantly different from commercial websites by 
a two-tailed Kruskal-Wallis test, followed by the Dunn’s post test). (B) Breakdown of the four 
components per typology. 
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Figure 5. Number of websites, trials and meta-analyses in the Cochrane database by indications. 
Data indicates the number of occurrences of an indication in websites (A), in clinical trials (B) and in 
reviews (C) 
 
 
 
Figure 6. Number of online claims with different levels of scientific evidence according to 
Cochrane reviews. Values do not add up to 150 as webpages can mention more than one probiotics’ 
benefit. 
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SUPPLEMENTARY FILES 
 
Typology Examples 
Commercial (C) https://draxe.com 
https://www.humnutrition.com 
Governmental (G) https://nccih.nih.gov 
https://www.nasa.gov 
News (N) https://www.womenshealthmag.com 
http://time.com 
https://www.theguardian.com 
Health portal (HP) https://www.webmd.com 
https://www.medicinenet.com 
Non-profit organization (NP) https://nutritionfacts.org 
Professionals (P) https://my.clevelandclinic.org 
https://www.health.harvard.edu 
Scientific journals (SJ) https://www.sciencedirect.com 
https://www.scientificamerican.com 
Other (O) https://en.wikipedia.org 
https://blog.paleohacks.com 
Supplementary Table 1. Examples of websites typologies 
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Criteria Examples Websites 
Cautionary 
note on 
probiotics 
health benefits 
- Kombucha is a fermented tea drink. It is claimed to have a wide 
range of health benefits, but more research is needed. 
(https://www.healthline.com/nutrition/11-super-healthy-probiotic-
foods) 
- However, benefits have not been conclusively demonstrated, and 
not all probiotics have the same effects. 
(https://nccih.nih.gov/health/probiotics/introduction.htm) 
Relevant 
scientific 
documentation 
- https://www.healthline.com/nutrition/11-super-healthy-probiotic-
foods 
- https://nccih.nih.gov/health/probiotics/introduction.htm 
Safety 
information on 
probiotics 
- In general, probiotic foods and supplements are thought to be safe 
for most people, though some people with immune system 
problems or other serious health conditions shouldn't take them. 
(https://www.webmd.com/digestive-disorders/what-are-probiotics) 
- What the Science Says About the Safety and Side Effects 
of Probiotics 
(https://nccih.nih.gov/health/probiotics/introduction.htm) 
Regulation on 
probiotics 
- The FDA regulates probiotics like foods, not like medications. 
Unlike drug companies, makers of probiotic supplements don't have 
to show their products are safe or that they work. 
(https://www.webmd.com/digestive-disorders/what-are-probiotics) 
Supplementary Table 2. Examples that satisfy each criterion of the score of completeness 
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